Pharma channel feed

Spark lines up next reti­nal gene ther­a­py pact in Barcelona

Last year
Deals
Cell/Gene Tx

Bris­tol My­ers scores an­oth­er Op­di­vo ap­proval, as Mer­ck con­verts AA to full ap­proval for Keytru­da in MCC

Last year
FDA+

Ab­b­Vie’s Skyrizi helps more Crohn's pa­tients stay off steroids than J&J’s Ste­lara, PhI­II da­ta show

Last year
R&D

No­vo Nordisk to buy PhI­II kid­ney dis­ease drug from Sin­ga­pore's KBP Bio­sciences

Last year
Deals

Up­dat­ed: Pfiz­er plans $3.5B in cost cuts amid Covid slide, while Mod­er­na sticks by guid­ance

Last year

Pfiz­er's El­rex­fio, Astel­las' Veozah among new drugs rec­om­mend­ed for au­tho­riza­tion by Eu­ro­pean reg­u­la­to­ry com­mit­tee

Last year
FDA+

Ex­clu­sive: Hori­zon CEO Tim Wal­bert talks M&A, FTC post-Am­gen deal close

Last year
People

Re­lay Ther­a­peu­tics points to drug price ne­go­ti­a­tions for de­lay in po­ten­tial block­buster can­cer drug

Last year
Law

No­vo rais­es 2023 out­look due to high­er than ex­pect­ed Ozem­pic and We­govy sales in the US

Last year

Op­ti­miz­eRx builds out pa­tient DTC mar­ket­ing with $95M ac­qui­si­tion

Last year
Deals
Marketing

BIO, PhRMA, oth­ers seek tweaks to FDA draft guid­ance on di­ver­si­ty in post­mar­ket­ing stud­ies

Last year
FDA+

Am­gen gives first glimpse at PRMT5 in­hibitor, days af­ter Bris­tol My­ers put a $1B promise on the tar­get

Last year
R&D

Pfiz­er lands FDA ap­proval for $6.7B ul­cer­a­tive col­i­tis drug, tak­ing on an­ti­bod­ies as an oral al­ter­na­tive

Last year
R&D
FDA+

San­thera gears up for EU launch of va­morolone in Duchenne af­ter pos­i­tive CHMP opin­ion

Last year

Flag­ship Pi­o­neer­ing re­casts its cor­po­rate brand with ‘Big­ger Leaps’ tagline and am­bi­tion

Last year
Marketing

More than 'just a rash': In­cyte taps Mandy Moore in atopic der­mati­tis cam­paign

Last year
Marketing

Qual­i­ty con­sid­er­a­tions for top­i­cal eye treat­ments: FDA pub­lish­es new draft guid­ance

Last year
FDA+

How an earn­ings call com­ment from Al San­drock pro­pelled an ap­peals court's re­ver­sal on a Bio­gen in­vestor suit

Last year
Law

FDA’s drug pro­mo­tion watch­dog plans study around ad­her­ence claims in phar­ma ads

Last year
Marketing

GSK looks to au­tho­rized gener­ic ver­sion of asth­ma treat­ment as Med­ic­aid re­bate caps lift next year

Last year
FDA+

Pfiz­er ex­pands la­bel for block­buster BRAF/MEK com­bo in­to lung can­cer

Last year

BioN­Tech sends $70M to an­oth­er ADC part­ner to go up against Dai­ichi Sankyo in HER3

Last year
Deals
China

Delaware judge ap­proves Mallinck­rodt's sec­ond bank­rupt­cy plan since 2020

Last year

Bio­gen cuts al­most one-third of Reata's staff fol­low­ing $7B buy­out

Last year
People
First page Previous page 9596979899100101 Next page Last page
A service from the Financial Times